Rocket Lab (RKLB) Stock Surges on Citi's Buy Rating and Major Launch Contract

Key Takeaways

Table of Contents

Wall Street bank Citi launched coverage of Rocket Lab (RKLB) with a Buy rating and $105 price target, suggesting 51% potential upside.
Citi’s John Godyn designated RKLB as a “core holding for space bulls.”
Shares of RKLB gained approximately 3% during Thursday’s opening session amid positive analyst commentary and fresh contract news.
The aerospace firm secured a 20-mission agreement with Synspective, marking its biggest commercial Electron contract to date.
This latest agreement elevates Rocket Lab’s overall launch backlog past the 100-mission threshold.

Shares of Rocket Lab (RKLB) advanced roughly 3% as Thursday’s trading session commenced. The positive momentum came on the heels of fresh Buy-rated coverage from Citi alongside the unveiling of a substantial new customer contract.

Rocket Lab USA, Inc., RKLB

Wall Street analyst John Godyn of Citi initiated research coverage on RKLB with a Buy recommendation and established a $105 price objective. This valuation suggests approximately 51% appreciation potential based on the stock’s previous close.

In his analysis, Godyn characterized Rocket Lab as essential portfolio material for investors bullish on the space sector. His thesis emphasized the company’s dual presence in both launch operations and spacecraft systems.

The company maintains operations spanning multiple segments of the commercial space industry. Its business touches rocket launch services, satellite hardware manufacturing, and ground-based launch facilities.

Analyst Highlights Electron Success and Business Model

Godyn emphasized that Rocket Lab stands among a select few firms delivering consistent commercial orbital access. He cited the Electron launch vehicle as evidence of the company’s operational reliability.

The Citi analyst also drew attention to Rocket Lab’s vertically integrated structure. This business model enables the firm to capture value beyond launch services alone, diversifying revenue streams across the space value chain.

The favorable analyst coverage coincided with Rocket Lab’s disclosure of its most substantial commercial Electron agreement ever. The company formalized a multi-year arrangement with Tokyo-based Earth observation company Synspective.

Under the terms, Rocket Lab will conduct 20 Electron missions. These flights will place Synspective’s StriX synthetic aperture radar imaging satellites into sun-synchronous orbital paths.

Mission execution is planned to occur between 2028 and 2031. All launches will take place from the company’s Launch Complex 1 facility located in New Zealand.

Mission Backlog Exceeds Century Mark

This fresh contract elevates Synspective’s total reserved Electron flights to 47. The Tokyo firm now holds the distinction of being Rocket Lab’s largest customer measured by mission volume.

According to Rocket Lab, this agreement alongside additional multi-mission contracts executed this year has driven its cumulative launch manifest beyond 100 scheduled flights. This expanded backlog provides enhanced forward visibility for the Electron program.

Company founder and CEO Peter Beck offered commentary on the partnership. He observed that satellite operators seeking greater mission control and scheduling flexibility frequently select Rocket Lab as their launch provider.

Beck emphasized that Synspective ranks among Electron’s original customers. He interpreted the contract expansion as validation of Electron’s demonstrated launch cadence and orbital insertion precision.

Meanwhile, Rocket Lab continues development of Neutron, its medium-lift reusable launch system, while Electron maintains robust commercial activity. The company operates both rocket programs concurrently as complementary rather than competing platforms.

TipRanks data shows RKLB maintains a Strong Buy consensus among Wall Street analysts. This rating reflects 14 Buy recommendations and two Hold ratings issued during the last three months.

The consensus analyst price target for Rocket Lab stands at $110.07. This valuation implies approximately 56% upside potential from present trading levels, modestly exceeding Citi’s stated target.

Neither Rocket Lab nor Synspective publicly revealed the financial parameters of their launch services agreement.

✨ Limited Time Offer